Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
23andMe Holding (ME)
NASDAQ:ME
23andMe Holding (ME) Stock Price & Analysis
1,137 Followers
ME Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.35 - $2.21
Previous Close$0.51
Volume59.61M
Average Volume (3M)7.45M
Market Cap
$244.11M
Enterprise Value$68.78M
Total Cash (Recent Filing)$256.39M
Total Debt (Recent Filing)$81.05M
Price to Earnings (P/E)-0.5
Beta1.86
Next Earnings
May 23, 2024EPS Estimate
-$0.17Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.10
Shares Outstanding482,916,636
10 Day Avg. Volume3,768,104
30 Day Avg. Volume7,448,103
Standard Deviation0.17
R-Squared0.17
Alpha-0.08
Financial Highlights & Ratios
Price to Book (P/B)0.87
Price to Sales (P/S)0.38
Price to Cash Flow (P/CF)-0.90
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.39
Enterprise Value/Gross Profit-0.42
Enterprise Value/Ebitda-0.68
Forecast
1Y Price Target
$1.24Price Target Upside145.30% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
23andMe Holding News
PremiumCompany Announcements
23andMe Forms Special Committee for Strategic Governance
PremiumCompany Announcements
23andMe CAO Kathy Hibbs Retires, Guy Chayoun Steps In
Bulls Say, Bears Say
Bulls Say
Corporate StrategyThe company is considering a split of their consumer/research business and their therapeutics business, which would likely unlock value on both fronts.
Drug Development23andMe presented data on two in-house immunotherapies, showcasing target discovery and therapeutic potential.
Regulatory MilestoneFDA Clears IND for 23ME-01473, A Dual Mechanism Ab Targeting, positioning 23andMe to initiate a Ph1 study of '1473 in patients with solid tumors.
Bears Say
Financial ForecastFY’2024 revenue guidance was lowered to $215M-$220M (from $240-$250M previously), which is ~11% lower than consensus expectations of $246M.
Legal And CybersecurityThe full financial impact from ongoing class action claims related to the company’s data theft remains unclear.
Regulatory ComplianceME shares remain out of compliance with Nasdaq rules requiring the stock price to be >$1.00, threatening its listing on the exchange.
---
Ownership Overview
2.74% Insiders
12.17% Mutual Funds
10.36% Other Institutional Investors
74.73% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
The estimated number of people who visited one or more of the websites owned by 23andMe Holding
Desktop Users
Mobile Users
ME FAQ
What was 23andMe Holding’s price range in the past 12 months?
23andMe Holding lowest stock price was $0.35 and its highest was $2.21 in the past 12 months.
What is 23andMe Holding’s market cap?
Currently, no data Available
When is 23andMe Holding’s upcoming earnings report date?
23andMe Holding’s upcoming earnings report date is May 23, 2024 which is in 34 days.
How were 23andMe Holding’s earnings last quarter?
23andMe Holding released its earnings results on Feb 07, 2024. The company reported -$0.58 earnings per share for the quarter, missing the consensus estimate of -$0.14 by -$0.44.
Is 23andMe Holding overvalued?
According to Wall Street analysts 23andMe Holding’s price is currently Undervalued.
Does 23andMe Holding pay dividends?
23andMe Holding does not currently pay dividends.
What is 23andMe Holding’s EPS estimate?
23andMe Holding’s EPS estimate is -$0.17.
How many shares outstanding does 23andMe Holding have?
23andMe Holding has 315,436,370 shares outstanding.
What happened to 23andMe Holding’s price movement after its last earnings report?
23andMe Holding reported an EPS of -$0.58 in its last earnings report, missing expectations of -$0.14. Following the earnings report the stock price went down -12.5%.
Which hedge fund is a major shareholder of 23andMe Holding?
Among the largest hedge funds holding 23andMe Holding’s share is Wexford Capital LP. It holds 23andMe Holding’s shares valued at 21K.
---
23andMe Holding Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$1.24 (145.30% Upside)
$1.24 (145.30% Upside)
Blogger Sentiment
Bullish
ME Sentiment 75%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 23.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 5.8%
Last 30 Days ▼ 5.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-82.96%
12-Months-Change
Fundamentals
Return on Equity
-92.53%
Trailing 12-Months
Asset Growth
-40.64%
Trailing 12-Months
Company Description
23andMe Holding
VG Acquisition Corp is a blank check company.
---
ME Earnings Call
Q3 2024
0:00 / 0:00
---
ME Revenue Breakdown
100.00% Consumer & Research Services
0.00% Therapeutics
---
ME Stock 12 Months Forecast
Average Price Target
$1.24
▲(145.30% Upside)
Technical Analysis
Best Analysts Covering ME
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-77.09%
reiterated a buy rating 8 months ago
Copying Gaurav Goparaju's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -77.09% per trade.
---